https://www.selleckchem.com/products/LBH-589.html
Channelling bias (confounding by indication), time-lag bias, conditioning on the future, database heterogeneity, linearity of eGFR change over time, and duration of observation are critical issues that may undermine the robustness of RWS findings. We then elaborate on the new opportunities to overcome such limitations by describing the design and objectives of the DARWIN (DApagliflozin Real-World evIdeNce)-Renal, a new RWS promoted by the Italian Diabetes Society. Fine-tuning of methods for comparative observational research will improv
Like
Comment
Share
